Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 2.31
-3.35 %
$ 4.61 M
Market Cap
-0.36
P/E
CASH FLOW STATEMENT
-7 M
OPERATING CASH FLOW
-3.52 K
INVESTING CASH FLOW
7.06 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Mangoceuticals, Inc.
| Net Income | -9.21 M |
| Depreciation & Amortization | 24.9 K |
| Capital Expenditures | -3.52 K |
| Stock-Based Compensation | 624 K |
| Change in Working Capital | 41.5 K |
| Others | 1.46 M |
| Free Cash Flow | -7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | |
|---|---|---|---|
| OPERATING CASH FLOW | |||
| Net Income | (9.2) | (2.0) | 17.7 K |
| Depreciation & Amortization | 24.9 K | 3.86 K | 0 |
| Deferred Income Tax | 0 | (0.2) | 0 |
| Stock Based Compensation | 0.6 | 0.2 | 0 |
| Other Operating Activities | 1.5 | 0.5 | 181 |
| Change in Working Capital | 41.5 K | 18.9 K | 0 |
| Cash From Operations | (7.0) | (1.3) | 17.5 K |
| INVESTING CASH FLOW | |||
| Capital Expenditures | 3.52 K | 43.1 K | 0 |
| Other Items | 0 | 0 | 0 |
| Cash From Investing Activities | 3.52 K | 43.1 K | 0 |
| FINANCING CASH FLOW | |||
| Common Stock Repurchased | 0 | 0 | 0 |
| Total Debt Repaid | (0.2) | 49.9 K | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 1.0 | 0 | 0.2 |
| Cash From Financing Activities | 7.1 | 2.0 | 40.1 K |
| CHANGE IN CASH | |||
| Net Change In Cash | 56.1 K | 0.7 | 22.6 K |
| FREE CASH FLOW | |||
| Free Cash Flow | (7.0) | (1.4) | 17.5 K |